Changes in Body Composition Assessed by Bioelectrical Impedance Analysis in Patients Treated with GLP-1 Receptor Agonists: A Real-World Experience.
OBJECTIVE Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) induce significant weight loss in patients with obesity; however, data on real-world body composition changes are limited. METHODS We conducted a retrospective real-world observational study including 388 obese adults treated with GLP-1 RAs and followed...